Haemonetics stock slides 7% as revenue dip and hospital softness blunt raised outlook

Haemonetics Corporation shares slumped roughly 7% Friday, despite the medical device company raising its full-year profit and cash flow forecast after posting quarterly numbers. The stock traded at $60.46 in the afternoon, down $4.56.